Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
IN8BIO, INC. issued 5,127,029 Shares of Common Stock, at a purchase price of $1.38 per Share of common stock to the Investors for aggregate gross proceeds of approximately $20.1 million.
- Security
- common stock
- Shares
- 5,127,029 Shares of Common Stock, at a purchase price of $1.38 per Share
- Purchaser
- the Investors
- Consideration
- aggregate gross proceeds of approximately $20.1 million
Exact text from the filing
to purchase up to 9,452,677 Warrant Shares, at a purchase price of $1.3799 per Pre-Funded Warrant (the “Pre-Funded Warrant Price”) for aggregate gross proceeds of approximately $20.1 million, before deducting placement agent fees and other private placement expenses. Pursuant to the Purchase Agreement, subject to the occurrence of the Second Closing Trigger (as
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
IN8BIO, INC. issued Pre-Funded Warrants to purchase up to 9,452,677 Warrant Shares, at a purchase price of $1.3799 per Pre-Funded Warrant of warrant to the Investors for aggregate gross proceeds of approximately $20.1 million.
- Security
- warrant
- Shares
- Pre-Funded Warrants to purchase up to 9,452,677 Warrant Shares, at a purchase price of $1.3799 per Pre-Funded Warrant
- Purchaser
- the Investors
- Consideration
- aggregate gross proceeds of approximately $20.1 million
Exact text from the filing
At the Initial Closing, the Company has agreed to issue and sell to the Investors an aggregate of 5,127,029 Shares of Common Stock, at a purchase price of $1.38 per Share (the “Share Price”), and, in lieu of Common Stock, Pre-Funded Warrants to purchase up to 9,452,677 Warrant Shares, at a purchase price of $1.3799 per Pre-Funded Warrant (the “Pre-Funded Warrant Price”) for aggregate gross proceeds of approximately $20.1 million, before deducting placement agent fees and other private placement expenses.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
IN8BIO, INC. entered into Securities Purchase Agreement with the purchasers named therein (the "Investors") valued at aggregate gross proceeds of approximately $20.1 million (effective 2025-12-18).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the purchasers named therein (the "Investors")
- Value
- aggregate gross proceeds of approximately $20.1 million
- Effective
- 2025-12-18
Exact text from the filing
On December 18, 2025, IN8bio, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Investors”)
View on SEC.gov